Yorktown Management & Research Company’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-26,700
Closed -$236K 226
2021
Q4
$236K Buy
+26,700
New +$254K 0.16% 230

Other funds holding SRTA

Yorktown Management & Research Company's SRTA Position: Q1 2022 in Review

Yorktown Management & Research Company sold out of Strata Critical Medical Inc (SRTA) in Q1 2022, closing a stake of 26,700 shares — an estimated $236K sold.

Yorktown Management & Research Company first reported a position in SRTA in Q4 2021 and held it in 1 quarter. The position peaked at $236K in Q4 2021. 78 funds tracked by Wall St. Rank hold SRTA as of Q1 2022.

  • Yorktown Management & Research Company reported no remaining Strata Critical Medical Inc position as of Q1 2022 after selling out during the quarter.
  • Yorktown Management & Research Company sold 26,700 Strata Critical Medical Inc shares in Q1 2022, an estimated $236K.
  • Yorktown Management & Research Company first reported a position in Strata Critical Medical Inc in Q4 2021 and held it in 1 quarter.
  • Yorktown Management & Research Company's Strata Critical Medical Inc position peaked at $236K in Q4 2021.
  • 78 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2022.

Based on Yorktown Management & Research Company's 13F filing for Q1 2022, filed 29 Apr 2022.